Story perspectives

Trump's Autism Treatment Claim Sparks Expert Backlash

9/26/2025

40 2

Summary

Story summary

President Trump's administration announced leucovorin, a vitamin B9 derivative, as autism treatment, surprising experts.
Critics say evidence is insufficient; autism groups distance themselves from approval.
Genetic factors are primary in autism; environmental influences unclear; vaccines not a cause.
Efficacy remains uncertain; studies show modest benefits; medical groups urge trials; Food and Drug Administration (FDA) label change could mislead families.

1 of 1

Story summary

President Trump's administration announced leucovorin, a vitamin B9 derivative, as autism treatment, surprising experts.
Critics say evidence is insufficient; autism groups distance themselves from approval.
Genetic factors are primary in autism; environmental influences unclear; vaccines not a cause.
Efficacy remains uncertain; studies show modest benefits; medical groups urge trials; Food and Drug Administration (FDA) label change could mislead families.